OSCR
Oscar Health, Inc. (OSCR)
Last Price$15.13.3%
Market Cap$3,703.3M
$9,177.6M
+56.6% YoY
($1,852.1M)
Net Debt to FCF - (1.9x)
$950.3M
10.4% margin

OSCR Income Statement

OSCR Income Statement Overview

Annual
Quarterly
LTM
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
$9,177.6M 56.5% YoY
$9,177.6M 56.5% YoY
100.0% margin
Operating income
$57.3M 0.0% YoY
0.6% margin
Other: $105.0K
Net interest: $23.7M
Operating expenses
$9,120.3M 49.6% YoY
Pre-tax income
$33.4M 0.0% YoY
0.4% margin
Net income
$25.4M 0.0% YoY
0.3% margin
Income tax
$7,305.0K
21.9% tax rate
SG&A
$1,755.9M 416.9% YoY
19.1% of revenue

OSCR Income statement key metrics

Annual
Quarterly
LTM

Revenue

$9,177.6M +56.5% YoY

Net Income

$25.4M N/A

OSCR Balance Sheet

OSCR Balance Sheet Overview

Annual
Quarterly
LTM
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Assets
Liabilities
Total assets
$4,840.5M
Current assets ($2,845.2M, 58.8% of total)
$2,151.6M (44.5%)
$315.9M (6.5%)
Other current assets
$377.6M (7.8%)
Non-current assets ($1,995.3M, 41.2% of total)
$1,815.3M (37.5%)
Other non-current assets
$113.3M (2.3%)
Financial position
($1,852.1M)
$2,151.6M$299.6M
Cash & Short-term Investments
Total Debt

OSCR Balance Sheet Metrics

Annual
Quarterly
LTM

Assets

$4,840.5M +44.1% YoY

Liabilities

$3,824.1M +49.7% YoY

Shareholder's Equity

$1,016.4M +26.1% YoY

OSCR Cash Flow Statement

OSCR Cash Flow Statement Overview

Annual
Quarterly
LTM
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Cash Beginning of PeriodOperating Cash FlowInvesting Cash FlowFinancing Cash FlowForex Changes on CashCash End of Period$1,892.0M$978.2M($1,387.4M)$68.4M$0.0$1,551.1M

OSCR Cash Flow Statement key metrics

Annual
Quarterly
LTM

Capital Expenditure (CAPEX)

($27.9M) +9.1% YoY

Free Cash Flow (FCF)

$950.3M N/A YoY

OSCR Financials

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
% growth
553.8
0.0%
589.6
6.5%
1,921.0
225.8%
4,125.6
114.8%
5,862.9
42.1%
9,177.6
56.5%
Cost of Goods Sold (COGS)0.00.00.00.00.00.0
% margin
553.8
100.0%
589.6
100.0%
1,921.0
100.0%
4,125.6
100.0%
5,862.9
100.0%
9,177.6
100.0%
Operating Expenses(814.2)(996.5)(2,498.0)4,553.56,098.59,120.3
Research & Development Expenses (R&D)0.00.00.00.00.00.0
Selling, General & Administrative Expenses (SG&A)110.7166.7265.1309.8339.71,755.9
(260.5)
(47.0%)
(406.9)
(69.0%)
(577.1)
(30.0%)
(584.2)
(14.2%)
(235.6)
(4.0%)
57.3
0.6%
Interest Income11.18.010.331.30.00.0
Interest Expense0.03.54.722.624.623.7
Pre-tax Income(259.4)(405.8)(570.6)(610.1)(267.3)33.4
% effective tax rate
1.8
(0.7%)
1.0
(0.3%)
0.8
(0.1%)
(0.5)
0.1%
3.3
(1.2%)
7.3
21.9%
% margin
(261.2)
(47.2%)
(406.8)
(69.0%)
(571.4)
(29.7%)
(609.6)
(14.8%)
(270.7)
(4.6%)
25.4
0.3%
EPS(1.09)(1.70)(3.19)(2.87)(1.22)0.11
Diluted EPS(1.09)(1.70)(3.19)(2.87)(1.22)0.10
% margin
(252.5)
(45.6%)
(391.0)
(66.3%)
(551.3)
(28.7%)
(572.2)
(13.9%)
(212.0)
(3.6%)
88.6
1.0%